Discover
HAE
Haemonetics Corporation
87.22
1 x 82.10
1 x 88.95
bid
ask
+
0.61
0.70%
1 @ 04:00 PM
87.22 +0.00 (0.00%)
| Ytd | 8.82% | |
| 1y | 66.23% |
86.10
day range
88.88
47.32
52 week range
88.88
| Open | 86.79 | Prev Close | 86.61 | Low | 86.10 | High | 88.88 | Mkt Cap | 3.96B |
| Vol | 0.00 | Avg Vol | 876.28K | EPS | 5.01 | P/E | 17.41 | Forward P/E | 15.09 |
| Beta | 0.52 | Short Ratio | 3.42 | Inst. Own | 111.32% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 77.07 | 200-d Avg | 68.71 | 1yr Est | 96.20 |
| Income Statement | |||
| Total Revenue | 339.38M | ||
| Revenues (USD) | 339.38M | ||
| Cost of Revenue | 136.58M | ||
| Gross Profit | 202.80M | ||
| Operating Expenses | 145.35M | ||
| Research and Development Expense | 16.20M | ||
| Selling, General and Administrative Expense | 118.94M | ||
| Operating Income | 57.46M | ||
| Interest Expense | 9.88M | ||
| Income Tax Expense | 14.56M | ||
| Net Income | 33.01M | ||
| Net Income Common Stock | 33.01M | ||
| Net Income Common Stock (USD) | 33.01M | ||
| Consolidated Income | 33.01M | ||
| Earnings per Basic Share | 0.73 | ||
| Earnings per Basic Share (USD) | 0.73 | ||
| Earnings per Diluted Share | 0.72 | ||
| Earning Before Interest & Taxes (EBIT) | 57.46M | ||
| Earning Before Interest & Taxes (USD) | 57.46M | ||
| Weighted Average Shares | 45.36M | ||
| Weighted Average Shares Diluted | 45.70M | ||
| Balance Sheet | |||
| Cash and Equivalents | 223.38M | ||
| Cash and Equivalents (USD) | 223.38M | ||
| Trade and Non-Trade Receivables | 216.07M | ||
| Current Assets | 810.83M | ||
| Property, Plant & Equipment Net | 303.78M | ||
| Total Assets | 2.37B | ||
| Debt Current | 4.96M | ||
| Total Debt | 1.17B | ||
| Current Liabilities | 263.24M | ||
| Debt Non-Current | 1.17B | ||
| Total Liabilities | 1.53B | ||
| Accumulated Retained Earnings (Deficit) | 311.52M | ||
| Accumulated Other Comprehensive Income | -41.63M | ||
| Shareholders Equity | 837.10M | ||
| Shareholders Equity (USD) | 837.10M | ||
| Assets Non-Current | 1.55B | ||
| Total Debt (USD) | 1.17B | ||
| Goodwill and Intangible Assets | 1.09B | ||
| Inventory | 306.74M | ||
| Liabilities Non-Current | 1.27B | ||
| Trade and Non-Trade Payables | 56.34M | ||
| Tax Assets | 9.43M | ||
| Tax Liabilities | 38.69M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 27.11M | ||
| Net Cash Flow from Financing | -51.53M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -22.06M | ||
| Capital Expenditure | -13.23M | ||
| Issuance (Purchase) of Equity Shares | 49.00K | ||
| Issuance (Repayment) of Debt Securities | -51.56M | ||
| Net Cash Flow from Investing | -22.23M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -9.00M | ||
| Net Cash Flow from Operations | 52.32M | ||
| Effect of Exchange Rate Changes on Cash | -617.00K | ||
| Share Based Compensation | 9.31M | ||